$384 Million is the total value of Integral Health Asset Management, LLC's 71 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 50.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTM | Buy | ANTHEM INC | $22,105,000 | +90.7% | 45,000 | +80.0% | 5.75% | +79.4% |
| CYTK | Buy | CYTOKINETICS INC | $17,301,000 | +16.8% | 470,000 | +44.6% | 4.50% | +9.8% |
| PFE | Buy | PFIZER INC | $15,531,000 | +31.5% | 300,000 | +50.0% | 4.04% | +23.7% |
| GMED | GLOBUS MED INCcl a | $13,280,000 | +2.2% | 180,000 | 0.0% | 3.46% | -3.9% | |
| PKI | Buy | PERKINELMER INC | $13,085,000 | -7.0% | 75,000 | +7.1% | 3.40% | -12.6% |
| CNC | Sell | CENTENE CORP DEL | $12,629,000 | -31.9% | 150,000 | -33.3% | 3.29% | -35.9% |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $12,178,000 | -9.9% | 250,000 | -16.7% | 3.17% | -15.3% |
| THC | Buy | TENET HEALTHCARE CORP | $11,175,000 | +71.0% | 130,000 | +62.5% | 2.91% | +60.8% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $10,294,000 | -40.8% | 311,000 | -24.0% | 2.68% | -44.4% |
| CCXI | Buy | CHEMOCENTRYX INC | $10,028,000 | +37.7% | 400,000 | +100.0% | 2.61% | +29.5% |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $9,920,000 | -1.7% | 215,000 | +79.2% | 2.58% | -7.5% |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $9,830,000 | +35.0% | 150,000 | +25.0% | 2.56% | +26.9% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $9,787,000 | +41.6% | 327,000 | +45.3% | 2.55% | +33.2% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $9,774,000 | +21.7% | 153,000 | +104.0% | 2.54% | +14.4% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $9,448,000 | +100.7% | 60,000 | +50.0% | 2.46% | +88.6% |
| CVS | Buy | CVS HEALTH CORP | $9,109,000 | +3.9% | 90,000 | +5.9% | 2.37% | -2.3% |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $7,532,000 | – | 120,000 | +100.0% | 1.96% | – |
| SGEN | New | SEAGEN INC | $7,203,000 | – | 50,000 | +100.0% | 1.87% | – |
| AMED | Sell | AMEDISYS INC | $6,892,000 | -14.9% | 40,000 | -20.0% | 1.79% | -20.0% |
| AZN | ASTRAZENECA PLCsponsored adr | $6,634,000 | +13.9% | 100,000 | 0.0% | 1.73% | +7.1% | |
| GH | New | GUARDANT HEALTH INC | $6,624,000 | – | 100,000 | +100.0% | 1.72% | – |
| ALKS | Buy | ALKERMES PLC | $6,578,000 | +465.6% | 250,000 | +400.0% | 1.71% | +431.7% |
| SWAV | New | SHOCKWAVE MED INC | $6,221,000 | – | 30,000 | +100.0% | 1.62% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $6,168,000 | +45.4% | 80,000 | +66.7% | 1.60% | +36.7% |
| MRK | New | MERCK & CO INC | $6,154,000 | – | 75,000 | +100.0% | 1.60% | – |
| CI | New | CIGNA CORP NEW | $5,990,000 | – | 25,000 | +100.0% | 1.56% | – |
| HRTX | Buy | HERON THERAPEUTICS INC | $5,720,000 | -16.5% | 1,000,000 | +33.3% | 1.49% | -21.5% |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $5,540,000 | +14.7% | 500,000 | +81.8% | 1.44% | +7.9% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $5,448,000 | – | 35,000 | +100.0% | 1.42% | – |
| KURA | Buy | KURA ONCOLOGY INC | $5,419,000 | +355.4% | 337,000 | +296.5% | 1.41% | +328.6% |
| SIBN | Buy | SI-BONE INC | $5,311,000 | +36.6% | 235,000 | +34.3% | 1.38% | +28.4% |
| ISRG | New | INTUITIVE SURGICAL INC | $4,827,000 | – | 16,000 | +100.0% | 1.26% | – |
| AGL | Buy | AGILON HEALTH INC | $4,436,000 | +31.4% | 175,000 | +40.0% | 1.15% | +23.6% |
| KROS | Buy | KEROS THERAPEUTICS INC | $4,405,000 | +115.1% | 81,000 | +131.4% | 1.15% | +102.1% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $4,103,000 | +41.1% | 238,000 | +19.0% | 1.07% | +32.7% |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $3,837,000 | – | 30,000 | +100.0% | 1.00% | – |
| NTLA | INTELLIA THERAPEUTICS INC | $3,634,000 | -38.5% | 50,000 | 0.0% | 0.95% | -42.2% | |
| NVRO | Buy | NEVRO CORP | $3,617,000 | +27.5% | 50,000 | +42.9% | 0.94% | +19.9% |
| INSM | Buy | INSMED INC | $3,525,000 | +61.8% | 150,000 | +87.5% | 0.92% | +52.1% |
| ARCT | Buy | ARCTURUS THERAPEUTICS HLDGS | $3,370,000 | +40.1% | 125,000 | +92.3% | 0.88% | +31.7% |
| ZLAB | New | ZAI LAB LTDadr | $3,299,000 | – | 75,000 | +100.0% | 0.86% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $3,281,000 | – | 35,000 | +100.0% | 0.85% | – |
| BIIB | Sell | BIOGEN INC | $3,159,000 | -62.4% | 15,000 | -57.1% | 0.82% | -64.6% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $3,083,000 | +93.3% | 140,000 | +40.0% | 0.80% | +81.9% |
| QURE | Buy | UNIQURE NV | $3,072,000 | +48.1% | 170,000 | +70.0% | 0.80% | +39.2% |
| RGNX | Buy | REGENXBIO INC | $2,987,000 | +21.8% | 90,000 | +20.0% | 0.78% | +14.4% |
| TFX | New | TELEFLEX INCORPORATED | $2,839,000 | – | 8,000 | +100.0% | 0.74% | – |
| AKRO | Buy | AKERO THERAPEUTICS INC | $2,838,000 | +57.8% | 200,000 | +135.3% | 0.74% | +48.2% |
| REPL | Buy | REPLIMUNE GROUP INC | $2,802,000 | +3.4% | 165,000 | +65.0% | 0.73% | -2.8% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $2,787,000 | -11.6% | 300,000 | +50.0% | 0.72% | -16.9% |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $2,735,000 | +17.5% | 85,000 | +70.0% | 0.71% | +10.6% |
| INSP | New | INSPIRE MED SYS INC | $2,567,000 | – | 10,000 | +100.0% | 0.67% | – |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $2,448,000 | – | 40,000 | +100.0% | 0.64% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $2,121,000 | +4.9% | 224,000 | +28.0% | 0.55% | -1.3% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $2,034,000 | +66.4% | 125,000 | +66.7% | 0.53% | +56.5% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $2,021,000 | -64.4% | 39,769 | -66.9% | 0.53% | -66.5% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $1,700,000 | +3.2% | 171,000 | +22.1% | 0.44% | -3.1% |
| PTCT | Sell | PTC THERAPEUTICS INC | $1,567,000 | -12.6% | 42,000 | -6.7% | 0.41% | -17.7% |
| DOCS | New | DOXIMITY INCcl a | $1,563,000 | – | 30,000 | +100.0% | 0.41% | – |
| LFST | New | LIFESTANCE HEALTH GROUP INC | $1,517,000 | – | 150,000 | +100.0% | 0.40% | – |
| INCY | Sell | INCYTE CORP | $1,430,000 | -35.1% | 18,000 | -40.0% | 0.37% | -38.9% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $1,147,000 | -57.8% | 35,000 | -66.0% | 0.30% | -60.4% |
| DTIL | Buy | PRECISION BIOSCIENCES INC | $1,078,000 | -16.8% | 350,000 | +100.0% | 0.28% | -21.5% |
| PMVP | New | PMV PHARMACEUTICALS INC | $1,041,000 | – | 50,000 | +100.0% | 0.27% | – |
| SRRA | New | SIERRA ONCOLOGY INC | $962,000 | – | 30,000 | +100.0% | 0.25% | – |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $837,000 | -21.6% | 90,000 | +20.0% | 0.22% | -26.1% |
| DNLI | Sell | DENALI THERAPEUTICS INC | $836,000 | -81.3% | 26,000 | -74.0% | 0.22% | -82.3% |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $583,000 | +46.1% | 201,000 | +123.3% | 0.15% | +38.2% |
| CMRX | Buy | CHIMERIX INC | $545,000 | -22.9% | 119,000 | +8.2% | 0.14% | -27.6% |
| Sell | AVALO THERAPEUTICS INC | $507,000 | -81.7% | 700,000 | -56.9% | 0.13% | -82.7% | |
| LBPH | Buy | LONGBOARD PHARMACEUTICALS IN | $254,000 | +74.0% | 47,600 | +58.7% | 0.07% | +65.0% |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -25,000 | -100.0% | -0.11% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -200,000 | -100.0% | -0.19% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.22% | – |
| LYEL | Exit | LYELL IMMUNOPHARMA INC | $0 | – | -140,000 | -100.0% | -0.30% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -250,000 | -100.0% | -0.51% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -130,000 | -100.0% | -0.58% | – |
| Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -150,000 | -100.0% | -0.69% | – | |
| MASI | Exit | MASIMO CORP | $0 | – | -10,000 | -100.0% | -0.81% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -30,000 | -100.0% | -0.90% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -50,000 | -100.0% | -0.92% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -20,000 | -100.0% | -0.94% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -100,000 | -100.0% | -1.22% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -45,000 | -100.0% | -1.61% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -20,000 | -100.0% | -1.74% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -50,000 | -100.0% | -1.87% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -130,000 | -100.0% | -2.10% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -70,000 | -100.0% | -2.73% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -55,000 | -100.0% | -3.78% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.